Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: Generic drug
Landmark decision on medicines and anti-counterfeiting law by Kenyan High Court
The Kenyan Anti-Counterfeit Act adopted in December 2008 contained an excessively broad definition of what constitutes a ‘counterfeit’ product that had the potential to include legally-manufactured generics. As such, legally manufactured and/or imported generic medicines of approved quality may be … Continue reading
Novartis’ deadly lawsuit
Novartis, a massive drug company, is suing the Government of India to protect profits and undercut the generic drug industry that saves millions of lives a year. Tell Novartis: Put patients over profits. Drop your lawsuit now. India produces most … Continue reading
Protest by AIDS activists in UK against India-EU FTA today
Affordable HIV medicines are being threatened!! 6 February 2012 After nearly four years of back and forth negotiating between the EU and India , on Friday 10th February the terms of the free trade agreement (FTA) will be announced at the EU-India Summit … Continue reading
Poser over medicine supplies:GLOBAL TRENDS
By MARTIN KHOR Source: The Star January 9, 2012 Patients worldwide suffering from various ailments have benefited from cheap generic Indian drugs. But will Indian companies be able to supply new drugs in the future? INDIA may be more famous … Continue reading
Generic Prescription Drugs saved $931 billion in United States in past 10 years, says US generic industry
Press Release by GPhA, 21 Sep 2011 New Study Finds Use of Generic Prescription Drugs Saved Consumers and the U.S. Health Care System $931 Billion Over Past 10 Years Savings Reached $158 Billion in 2010, Averaging $3 Billion Weekly WASHINGTON, … Continue reading
Posted in Drug Pricing, Generic drug, IP Rights
Tagged Generic drug, Generic Pharmaceutical Association, United States
Leave a comment
Controversial Trans-Pacific Free Trade Talks End
Progress Illinois Aaron Krager, Friday September 16th Trade talks for a Trans-Pacific Free Trade Agreement ended yesterday at the Hilton Hotel in the world’s fourth most economically powerful city in the world. It seems only fitting Chicago, a city with … Continue reading
Open Letter from Thai Civil Society: One Step forward, Two Steps back: the Agreement between the Medicine Patent Pool and Gilead Sciences, Inc
On behalf of the Thai Network of People Living with HIV & AIDS, pharmaceutical academics and civil society organisations working on access to medicines for all in Thailand, we wish to raise our grave concerns regarding the agreement between the … Continue reading
Posted in Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Antiretroviral drug, Generic drug, Gilead Sciences, Patent pool, Thailand
Leave a comment
Medicine Patent Pool’s agreement with Gilead: Is it really a fair deal?
Recently, Medicine Patent Pool signed its first agreement with pharmaceutical company Gilead for the production of the HIV medicines tenofovir, emtricitabine, cobicistat, and elvitegravir as well as a combination of these products in a single pill known as the “Quad.” Click … Continue reading
Posted in Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Aids, Generic drug, Gilead Sciences, HIV, Patent pool, Tenofovir, Unitaid
Leave a comment
Global Access Licensing as means to increase access to medicines
Read here an interesting blog article by UAEM suggesting Global Access Licensing as means for ensuring that public funded research on medical innovation reaches to people living in the developing countries on affordable prices. Global Access Licensing would allow generic … Continue reading
Vietnam and the Trans-Pacific Partnership Agreement
The Trans-Pacific Partnership free trade agreement being currently negotiated is proving to be retrograde to the fight against HIV in Vietnam. According to a June 16 article in the Public Citizen: The leaked U.S. proposal for the intellectual property chapter of the … Continue reading
Posted in data exclusivity, Generic drug, HIV/Aids, TPPA, Trans-Pacific Partnership Agreement, TRIPS plus, Uncategorized
Tagged Generic drug, HIV, TPPA, United States, Vietnam
1 Comment
